Bonus Share Alert: 1:20 Ratio, Record Date March 26; Will The Pharma Stock Spark A Fresh Upside Rally?

In addition to producing a large variety of oncology (anti-cancer) medications in India, Beta Drugs Ltd. is the industry leader in a variety of dermatological remedies. On September 21, 2005, Beta Drugs Limited was established as a private limited company in Himachal Pradesh under the name Beta Drugs Private Limited. Following the Board's announcement of the record date for 1:20 bonus shares, the leading pharma stock closed Friday's trading session on the NSE 4.86% higher at Rs 1,940 per share, with a market capitalization of Rs 1,865.09 Cr. This implies that if you hold 20 shares of Beta Drugs on the record date, you will get one additional share as a bonus.

Beta Drugs Bonus Shares Record Date

"This is further to our letters dated 12th March, 2025 wherein the Company had informed that the Shareholders had vide Special Resolution through Postal Ballot approved the issuance of Bonus Shares in the ratio of 1:20 i.e., 1 (One) new fully paid-up equity share of Rs. 10/- (Rupees Ten only) each for every 20 (Twenty) existing fully paid-up equity share of Rs. 10/- (Rupees Ten only) each, held by the Shareholders of the Company. In this regard, we wish to inform you that the Board of Directors of the Company has fixed Wednesday, 26th March, 2025 as the Record Date for the purpose of determining the equity shareholders of the Company eligible for bonus equity shares of the Company and the deemed allotment dated will be 27th March, 2025," said Beta Drugs in a stock exchange filing.

Intimation of Forthcoming Board Meeting of Beta Drugs Regarding Bonus Issue

"We would like to inform you that a meeting of the Board of Directors of the company has been scheduled to be held on Thursday, 27th day of March, 2025 at Corporate Office of the company situated at SCO 184, Sector-5, Panchkula-134114 to interalia, transact the following business:- 1. To consider and approve the allotment of 4,80,693 fully paid-up equity shares of the Company of face value of INR 10 each, under Bonus Issue," informed Beta Drugs to stock exchanges.

Beta Drugs Bonus Shares Issuance Date

"The Board of Directors at its meeting held on 5th February, 2025, subject to consent of the members of the Company, approved and recommended issue of bonus equity shares of Rs. 10- (Rupees Ten only) each credited as fully paid-up to eligible members of the Company in the proportion of 1:20 i.e. 1(One) equity shares of nominal value Rs.10/- (Rupees Ten Only) each for every 20 (Twenty) equity share of nominal value of Rs.10/- (Rupees Ten Only) each by capitalizing a sum not exceeding Rs.51,60,760 (Rupees Fifty one lakh sixty thousand seven hundred Sixty only) (including reservation to the CCD Holders) out of securities premium account and/or any other permitted reserves / surplus of the Company, as may be considered appropriate," stated Beta Drugs in an exchange filing.

Beta Drugs Share Price Target

"Beta Drugs stock price is bullish on the Daily charts with strong support at 1805. A Daily close above resistance of 1950 could lead to a target of 2120 in the near term," stated A R Ramachandran, Independent Research Analyst.

Disclaimer

The recommendations made above are by market analysts and are not advised by either the author, nor Greynium Information Technologies. The author, nor the brokerage firm nor Greynium would be liable for any losses caused as a result of decisions based on this write-up. Goodreturns.in advises users to consult with certified experts before making any investment decision.